The Centers for Disease Control and Prevention last week recommended Pfizer’s updated COVID-19 vaccine booster for Americans aged 12 and older and Moderna’s updated COVID-19 vaccine booster for Americans aged 18 and older, as recommended by its vaccine advisory committee. Authorized by the Food and Drug Administration Aug. 31, the updated boosters are bivalent, meaning they help protect against the most recently circulating omicron variants as well as the original virus strain.  

“This recommendation followed a comprehensive scientific evaluation and robust scientific discussion,” said CDC Director Rochelle Walensky, M.D. “If you are eligible, there is no bad time to get your COVID-19 booster and I strongly encourage you to receive it.”

Related News Articles

Headline
The COVID-19 monoclonal antibody therapy Evusheld may not prevent COVID-19 caused by certain variants of the virus, the Food and Drug Administration announced…
Headline
Increasing bivalent COVID-19 booster vaccinations this year to 2020-2021 flu vaccination rates could prevent an additional 75,000 deaths and 745,000…
Headline
The New Hampshire Hospital Association and the Foundation for Healthy Communities Sept. 29 received a Power of Associations Gold Award for their efforts during…
Perspective
With fall in full swing, there are two easy steps that individuals can take to protect themselves and their families against illness — get a flu shot and get a…
Headline
In a study of 151 tax-exempt hospitals reported yesterday in JAMA Network Open, 84% updated their charity care policies between 2019 and 2021. Among the…
Headline
Pfizer has submitted a request for the Food and Drug Administration to authorize a 10-microgram booster dose of its bivalent COVID-19 vaccine booster for…